Normal aging of the nervous system
1991; Wiley; Volume: 30; Issue: 2 Linguagem: Inglês
10.1002/ana.410300213
ISSN1531-8249
AutoresDonald B. Calne, Andrew Eisen, Graydon S. Meneilly,
Tópico(s)Neurological and metabolic disorders
ResumoAnnals of NeurologyVolume 30, Issue 2 p. 206-207 Issues in Clinical Neuroscience Normal aging of the nervous system Dr. D. B. Calne DM, Corresponding Author Dr. D. B. Calne DM Neurodegenerative Disorders Centre, University Hospital, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaNeurodegenerative Disorders Centre, University Hospital, UBC Site, Department of Medicine, 2211 Wesbrook Mall, Vancouver, BC V6T 1W5, CanadaSearch for more papers by this authorA. Eisen MD, A. Eisen MD Neurodegenerative Disorders Centre, University Hospital, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaSearch for more papers by this authorG. Meneilly MD, G. Meneilly MD Neurodegenerative Disorders Centre, University Hospital, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaSearch for more papers by this author Dr. D. B. Calne DM, Corresponding Author Dr. D. B. Calne DM Neurodegenerative Disorders Centre, University Hospital, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaNeurodegenerative Disorders Centre, University Hospital, UBC Site, Department of Medicine, 2211 Wesbrook Mall, Vancouver, BC V6T 1W5, CanadaSearch for more papers by this authorA. Eisen MD, A. Eisen MD Neurodegenerative Disorders Centre, University Hospital, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaSearch for more papers by this authorG. Meneilly MD, G. Meneilly MD Neurodegenerative Disorders Centre, University Hospital, Department of Medicine, University of British Columbia, Vancouver, British Columbia, CanadaSearch for more papers by this author First published: August 1991 https://doi.org/10.1002/ana.410300213Citations: 27AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Duara R, Margolin RA, Robertson-Tchabo EA, et al. Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. Brain 1983 106 761–775. 2 Sawle GV, Colebatch JG, Shah A, et al. Striatal function in normal aging: implications for Parkinson's disease. Ann Neurol 1990 28 799–804. 3 Morris JC., Drazner M, Fulling K. Clinical and pathological aspects of parkinsonism in Alzheimer's disease. Arch Neurol 1989 46 651–657. 4 Katzman R, Terry R Normal aging of the nervous system. In: R Katzman, RD Terry, eds. The Neurology of Aging. Philadelphia: FA Davis, 1983: 15–50. 5 Calne DB, Calne JS. Normality and disease. Can J Neurol Sci 1988 15 3–4. 6 Rowe JW, Kahn RL. Human aging: usual and successful. Science 1987 237 143–149. 7 Kuhl DE, Metter EJ, Riege WH, Phelps ME. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F] fluorodeoxyglucose method. J Cereb Blood Flow Metab 1982 2 163–171. 8 Martin WRW, Palmer MR, Patlak CS, Calne DB. Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol 1989 26 535–542. Citing Literature Volume30, Issue2August 1991Pages 206-207 ReferencesRelatedInformation
Referência(s)